• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Expert Consensus on the Diagnosis and Treatment of Bone Metastasis in Lung Cancer (2019 Version)].

出版信息

Zhongguo Fei Ai Za Zhi. 2019 Apr 20;22(4):187-207. doi: 10.3779/j.issn.1009-3419.2019.04.01.

DOI:10.3779/j.issn.1009-3419.2019.04.01
PMID:31014437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6500496/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/c04bc5cdd048/zgfazz-22-4-187-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/abba5869c851/zgfazz-22-4-187-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/708d019d8d19/zgfazz-22-4-187-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/be9be83f6730/zgfazz-22-4-187-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/c04bc5cdd048/zgfazz-22-4-187-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/abba5869c851/zgfazz-22-4-187-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/708d019d8d19/zgfazz-22-4-187-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/be9be83f6730/zgfazz-22-4-187-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2232/6500496/c04bc5cdd048/zgfazz-22-4-187-4.jpg

相似文献

1
[Expert Consensus on the Diagnosis and Treatment of Bone Metastasis in Lung Cancer (2019 Version)].《肺癌骨转移诊疗专家共识（2019年版）》
Zhongguo Fei Ai Za Zhi. 2019 Apr 20;22(4):187-207. doi: 10.3779/j.issn.1009-3419.2019.04.01.
2
[Chinese expert consensus on multidisciplinary treatment of bone metastasis from colorectal cancer (2020 version)].《中国结直肠癌骨转移多学科综合治疗专家共识（2020年版）》
Zhonghua Zhong Liu Za Zhi. 2020 Jun 23;42(6):433-437. doi: 10.3760/cma.j.cn112152-20200402-00295.
3
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition).《中国肺癌骨转移诊疗专家共识（2022年版）》
J Natl Cancer Cent. 2023 Aug 19;3(4):256-265. doi: 10.1016/j.jncc.2023.08.004. eCollection 2023 Dec.
4
[Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version)].《肺癌骨转移诊断与治疗专家共识（2014版）》
Zhongguo Fei Ai Za Zhi. 2014 Feb;17(2):57-72. doi: 10.3779/j.issn.1009-3419.2014.02.01.
5
[Expert consensus on diagnosis and treatment of renal cell cancer bone metastasis (2021 edition)].肾细胞癌骨转移诊疗专家共识（2021年版）
Zhonghua Zhong Liu Za Zhi. 2021 Oct 23;43(10):1007-1015. doi: 10.3760/cma.j.cn112152-20210709-00505.
6
[Chinese expert consensus on diagnosis and treatment of pulmonary nodules(2024)].《肺结节诊治中国专家共识（2024年版）》
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Aug 12;47(8):716-729. doi: 10.3760/cma.j.cn112147-20231109-00300.
7
[Expert consensus on renal cell carcinoma with bone metastasis (2020 Edition)].《肾细胞癌骨转移专家共识（2020年版）》
Zhonghua Zhong Liu Za Zhi. 2020 Jul 23;42(7):537-542. doi: 10.3760/cma.j.cn112152-20200401-00292.
8
[Chinese expert consensus on antiangiogenic drugs for advanced non-small cell lung cancer (2020 Edition)].《中国晚期非小细胞肺癌抗血管生成药物专家共识（2020年版）》
Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1063-1077. doi: 10.3760/cma.j.cn112152-20200918-00836.
9
CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis.中国临床肿瘤学会（CSCO）乳腺癌脑转移诊断和治疗专家共识
Transl Breast Cancer Res. 2022 Jul 30;3:22. doi: 10.21037/tbcr-22-30. eCollection 2022.
10
[Diagnosis and treatment of bone metastasis of renal cancer: an expert consensus statement (2008 version)].[肾癌骨转移的诊断与治疗：专家共识声明（2008版）]
Zhonghua Zhong Liu Za Zhi. 2010 Apr;32(4):317-9.

引用本文的文献

1
Risk factors of bone metastasis in lung adenocarcinoma.肺腺癌骨转移的危险因素
BMC Pulm Med. 2025 Jul 2;25(1):299. doi: 10.1186/s12890-025-03702-0.
2
Worldwide research trends on bone metastases of lung cancer: a bibliometric analysis.肺癌骨转移的全球研究趋势：一项文献计量分析。
Front Oncol. 2024 Oct 25;14:1429194. doi: 10.3389/fonc.2024.1429194. eCollection 2024.
3
Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (), involved in lung adenocarcinoma bone metastasis via MYC activation, and associated with tumor immune infiltration.

本文引用的文献

1
The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases.脊柱转移瘤立体定向体部放射治疗时代及复杂病例的多学科管理。
Neurooncol Pract. 2016 Mar;3(1):48-58. doi: 10.1093/nop/npv022. Epub 2015 Jul 27.
2
Bone Metastasis: Find Your Niche and Fit in.骨转移：找到你的定位并融入其中。
Trends Cancer. 2019 Feb;5(2):95-110. doi: 10.1016/j.trecan.2018.12.004. Epub 2019 Jan 17.
3
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
miR-320a作为CDGSH铁硫结构域2潜在负调控因子的生物信息学预测，其通过MYC激活参与肺腺癌骨转移，并与肿瘤免疫浸润相关。
Transl Cancer Res. 2024 Aug 31;13(8):4485-4499. doi: 10.21037/tcr-24-1188. Epub 2024 Aug 27.
4
Bioinformatic analysis of differentially expressed genes in lung cancer bone metastasis and their implications for disease progression in lung cancer patients.肺癌骨转移中差异表达基因的生物信息学分析及其对肺癌患者疾病进展的影响。
J Thorac Dis. 2024 Jul 30;16(7):4666-4677. doi: 10.21037/jtd-24-1081. Epub 2024 Jul 26.
5
Clinical practice guidelines for full-cycle standardized management of bone health in breast cancer patients.乳腺癌患者骨健康全周期标准化管理临床实践指南
Cancer Innov. 2024 Feb 29;3(1):e111. doi: 10.1002/cai2.111. eCollection 2024 Feb.
6
Development and validation of an early diagnosis model for bone metastasis in non-small cell lung cancer based on serological characteristics of the bone metastasis mechanism.基于骨转移机制血清学特征的非小细胞肺癌骨转移早期诊断模型的建立与验证
EClinicalMedicine. 2024 Apr 26;72:102617. doi: 10.1016/j.eclinm.2024.102617. eCollection 2024 Jun.
7
Effects of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Cancer Induced Bone Pain Relief in Patients with Non-Small Cell Lung Cancer: Study Protocol for a Randomized Controlled Trial.患者自控经皮穴位电刺激对非小细胞肺癌患者癌性骨痛缓解的影响：一项随机对照试验的研究方案
J Pain Res. 2024 Mar 26;17:1285-1298. doi: 10.2147/JPR.S437296. eCollection 2024.
8
Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study.常见实体瘤初诊时骨转移的流行率和预后：一项基于人群的研究。
BMJ Open. 2023 Oct 21;13(10):e069908. doi: 10.1136/bmjopen-2022-069908.
9
Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC.CT 放射组学和临床特征在预测 NSCLC 患者骨转移中的价值。
Contrast Media Mol Imaging. 2022 Aug 22;2022:7642511. doi: 10.1155/2022/7642511. eCollection 2022.
10
[Comprehensive Treatment of An Advanced Lung Cancer Patient with 
EGFR Driver Gene Positive].[表皮生长因子受体驱动基因阳性晚期肺癌患者的综合治疗]
Zhongguo Fei Ai Za Zhi. 2021 Jun 20;24(6):447-452. doi: 10.3779/j.issn.1009-3419.2021.101.20.
转移性非小细胞肺癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
4
[Cement augmentation for vertebral osteolytic metastatic lesions: an evaluation on postoperative CT].[骨水泥强化治疗椎体溶骨性转移瘤：术后CT评估]
Zhonghua Yi Xue Za Zhi. 2018 Sep 4;98(33):2661-2665. doi: 10.3760/cma.j.issn.0376-2491.2018.33.010.
5
Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions.立体定向体部放射治疗用于肺部、脊柱及寡转移疾病：当前证据与未来方向
Ann Transl Med. 2018 Jul;6(14):283. doi: 10.21037/atm.2018.06.40.
6
Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition).专家共识研讨会报告：原发性和转移性肺肿瘤热消融指南（2018年版）
J Cancer Res Ther. 2018;14(4):730-744. doi: 10.4103/jcrt.JCRT_221_18.
7
Cancer incidence and mortality in China, 2014.2014年中国的癌症发病率和死亡率
Chin J Cancer Res. 2018 Feb;30(1):1-12. doi: 10.21147/j.issn.1000-9604.2018.01.01.
8
Expert consensus statement on computed tomography-guided I radioactive seeds permanent interstitial brachytherapy.计算机断层扫描引导下I放射性粒子永久性组织间近距离治疗专家共识声明
J Cancer Res Ther. 2018 Jan;14(1):12-17. doi: 10.4103/jcrt.JCRT_888_17.
9
Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.实体瘤患者骨转移的发生率：对美国肿瘤电子病历的分析。
BMC Cancer. 2018 Jan 6;18(1):44. doi: 10.1186/s12885-017-3922-0.
10
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study.在 MOVEST 研究中，每月口服伊班膦酸钠 100mg 与每月静脉注射伊班膦酸钠 1mg 对于各种病症的患者同样有效。
J Bone Miner Metab. 2018 May;36(3):336-343. doi: 10.1007/s00774-017-0839-2. Epub 2017 Apr 7.